Prehospital Stroke Triage: A Modeling Study on the Impact of Triage Tools in Different Regions.


Journal

Prehospital emergency care
ISSN: 1545-0066
Titre abrégé: Prehosp Emerg Care
Pays: England
ID NLM: 9703530

Informations de publication

Date de publication:
2023
Historique:
medline: 7 7 2023
pubmed: 23 5 2023
entrez: 23 5 2023
Statut: ppublish

Résumé

Direct transportation to a thrombectomy-capable intervention center is beneficial for patients with ischemic stroke due to large vessel occlusion (LVO), but can delay intravenous thrombolytics (IVT). The aim of this modeling study was to estimate the effect of prehospital triage strategies on treatment delays and overtriage in different regions. We used data from two prospective cohort studies in the Netherlands: the Leiden Prehospital Stroke Study and the PRESTO study. We included stroke code patients within 6 h from symptom onset. We modeled outcomes of Rapid Arterial oCclusion Evaluation (RACE) scale triage and triage with a personalized decision tool, using drip-and-ship as reference. Main outcomes were overtriage (stroke code patients incorrectly triaged to an intervention center), reduced delay to endovascular thrombectomy (EVT), and delay to IVT. We included 1798 stroke code patients from four ambulance regions. Per region, overtriage ranged from 1-13% (RACE triage) and 3-15% (personalized tool). Reduction of delay to EVT varied by region between 24 ± 5 min ( In this modeling study, we showed that prehospital triage reduced time to EVT without disproportionate IVT delay, compared to a drip-and-ship strategy. The effect of triage strategies and the associated overtriage varied between regions. Implementation of prehospital triage should therefore be considered on a regional level.

Sections du résumé

BACKGROUND AND PURPOSE
Direct transportation to a thrombectomy-capable intervention center is beneficial for patients with ischemic stroke due to large vessel occlusion (LVO), but can delay intravenous thrombolytics (IVT). The aim of this modeling study was to estimate the effect of prehospital triage strategies on treatment delays and overtriage in different regions.
METHODS
We used data from two prospective cohort studies in the Netherlands: the Leiden Prehospital Stroke Study and the PRESTO study. We included stroke code patients within 6 h from symptom onset. We modeled outcomes of Rapid Arterial oCclusion Evaluation (RACE) scale triage and triage with a personalized decision tool, using drip-and-ship as reference. Main outcomes were overtriage (stroke code patients incorrectly triaged to an intervention center), reduced delay to endovascular thrombectomy (EVT), and delay to IVT.
RESULTS
We included 1798 stroke code patients from four ambulance regions. Per region, overtriage ranged from 1-13% (RACE triage) and 3-15% (personalized tool). Reduction of delay to EVT varied by region between 24 ± 5 min (
CONCLUSIONS
In this modeling study, we showed that prehospital triage reduced time to EVT without disproportionate IVT delay, compared to a drip-and-ship strategy. The effect of triage strategies and the associated overtriage varied between regions. Implementation of prehospital triage should therefore be considered on a regional level.

Identifiants

pubmed: 37219931
doi: 10.1080/10903127.2023.2215859
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

630-638

Auteurs

Martijne H C Duvekot (MHC)

Department of Neurology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Bjarty L Garcia (BL)

Department of Public Health and Primary care, Leiden University Medical Center, Leiden, The Netherlands.

Luuk Dekker (L)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Truc My Nguyen (TM)

Department of Neurology, Haga Hospital, The Hague, The Netherlands.

Ido R van den Wijngaard (IR)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.

Karlijn F de Laat (KF)

Department of Neurology, Haga Hospital, The Hague, The Netherlands.

Els L L M de Schryver (ELLM)

Department of Neurology, Alrijne Hospital, Leiderdorp, The Netherlands.

Loet M H Kloos (LMH)

Department of Neurology, Groene Hart Hospital, Gouda, The Netherlands.

Leo A M Aerden (LAM)

Department of Neurology, Reinier De Graaf Gasthuis, Delft, The Netherlands.

Stas A Zylicz (SA)

Department of Neurology, LangeLand Hospital, Zoetermeer, The Netherlands.

Jan Bosch (J)

Ambulance Services Holland-Midden, Leiden, The Netherlands.

Eduard van Belle (E)

Emergency Medical Services Haaglanden, The Hague, The Netherlands.

Erik W van Zwet (EW)

Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Anouk D Rozeman (AD)

Department of Neurology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

Walid Moudrous (W)

Department of Neurology, Maasstad Hospital, Rotterdam, The Netherlands.

Frédérique H Vermeij (FH)

Department of Neurology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.

Hester F Lingsma (HF)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Jeannette Bakker (J)

Department of Radiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

Pieter Jan van Doormaal (PJ)

Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Adriaan C G M van Es (ACGM)

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Aad van der Lugt (A)

Department of Emergency Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Marieke J H Wermer (MJH)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Diederik W J Dippel (DWJ)

Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Henk Kerkhoff (H)

Department of Neurology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

Bob Roozenbeek (B)

Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Nyika D Kruyt (ND)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Esmee Venema (E)

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Department of Emergency Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH